XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.09

+4.5%

3:55 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (7711)	11/11/1998 5:50:00 PM
From: aknahow	of 17367

Old friends, have not seen this one for some time. Note the reference to the meningococemia trial as being an example of the type of sepsis trial that makes more sense. thelancet.com "It is time to stop planning large, multicentre trials based on current definitions. Instead, we should aim to identify well-defined, homogeneous populations based on clinical and microbiological criteria and carry out proof-of-principle studies with agents selected on the basis of well-understood modes of action. Trials of anti-endotoxin agents in meningococcal sepsis are a good example."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next